Bone Marrow TransplantationTransplantation, HomologousPeripheral Blood Stem Cell TransplantationGraft vs Host DiseaseBone MarrowHematopoietic Stem Cell TransplantationTransplantation, AutologousBone Marrow CellsTransplantation ConditioningWhole-Body IrradiationHematopoietic Stem Cell MobilizationLeukemiaBusulfanAnemia, AplasticHematopoietic Stem CellsTransplantation ChimeraGraft SurvivalHematologic NeoplasmsTissue DonorsGranulocyte Colony-Stimulating FactorLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCyclophosphamideRecurrenceHistocompatibility TestingLeukocyte TransfusionHistocompatibilityLeukapheresisCombined Modality TherapyGraft vs Tumor EffectRemission InductionBone and BonesStem CellsAntigens, CD34Leukemia, Myeloid, AcuteLymphocyte DepletionGraft vs Leukemia EffectPrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow PurgingTreatment OutcomeHematopoiesisTransplantation, IsogeneicRadiation ChimeraBlood Component RemovalImmunosuppressive AgentsAcute DiseaseGraft vs Host ReactionT-LymphocytesLymphocyte TransfusionTime FactorsAntineoplastic Combined Chemotherapy ProtocolsLeukemia, MyeloidLymphoma, Non-HodgkinMice, Inbred C57BLMyelodysplastic SyndromesStem Cell TransplantationMultiple MyelomaMelphalanBone Marrow DiseasesImmunosuppressionNuclear FamilyChimeraHepatic Veno-Occlusive DiseaseSurvival AnalysisCyclosporineCytomegalovirus InfectionsRetrospective StudiesBlood CellsTransplantation ImmunologyEtoposideCytarabineHematologic DiseasesSurvival RateHLA AntigensDisease-Free SurvivalFatal OutcomeLeukocyte CountFlow CytometryInfectionGraft RejectionCord Blood Stem Cell TransplantationColony-Forming Units AssayImmunophenotypingBlood Cell CountMice, Inbred BALB CLymphomaFollow-Up StudiesActuarial AnalysisSalvage TherapyCell SeparationCell DifferentiationNeoplasm, ResidualLeukemia, Myelomonocytic, AcuteAntigens, CDBone Marrow ExaminationCells, CulturedMethotrexateMyeloablative AgonistsBone RemodelingAntineoplastic Agents, AlkylatingSpleen